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INTRODUCTION 
The 21
st century is considered the “human” century, 
the  underlying  reason  of  which  is  the  increasingly 
serious issue of declining birth rate and aging population 
shared  by  advanced  nations.  By  the  latter  half  of  this 
century,  countries  bearing  large  populations  such  as 
China and India will also eventually begin to experience 
aging of their populations. Therefore, the development of 
technologies related to medical care, health, and welfare 
are  considered  extremely  crucial.  In  addition  to 
expectations  for  the  development  of  medical 
technologies arising from needs of the global economy, 
there are also increasing expectations for the creation of 
new  medical  technologies  stemming  from  trends  in 
development and practical application of the life sciences. 
AIST’s  Second  Period  Research  Strategy  of  the  AIST 
(National  Institute  of  Advanced  Industrial  Science  and 
Technology)  in  Japan  established  in  April  2006  also 
clearly  states  that  developments  in  science  and 
technology  focusing  on  humans  will  become  the 
mainstream  future  trend  (Figure  1).  Furthermore,  a 
strategic target has been set in the field of health with 
regards to research strategies for the area of life sciences. 
At  the  beginning  of  last  year,  AIMBE  (American 
Institute  for  Medical  and  Biological  Engineering) 
conducted a survey for the purpose of assessing the role 
that  medical  equipment  and  technology  has  played  in 
clinical  medicine  since  the  1950s.  The  medical 
equipment  that  contributed  most  to  clinical 
medicine/medical care in the 20
th century were chosen 
for each ten-year period (Figure 2). The list contained 
equipment/technologies that anybody would agree upon, 
clearly  showing  significant  support  of  medical 
instruments in the development of leading-edge medical 
care. 
Development  of  biomedical  instrumentation 
technology  to  measure  the  physical  and  chemical 
information and signals emitted by the living body in a 
minimally  (or  non-)  invasive  and  continuous  manner, 
was  responsible  for  establishment  of  the  concept  of 
patient  monitoring  within  clinical  medicine.  It  thus 
contributed  greatly  to  “enhancement  of  the  quality  of 
medical  care.”  Furthermore,  the  technology  such  as 
medical  imaging  evolved  into  two-dimensional  from 
one-dimensional  measurements,  and  was  further 
developed  into  three-dimensional  measurements,  and 
made speedier as well. Now, it is not an overstatement to 
say that medical imaging has entered four-dimensional 
measurement.  Meanwhile,  treatment  technologies  have 
also  progressed  from  highly  invasive  operative 
treatments  to  minimally  invasive  techniques  such  as 
endoscopic surgery. At the end of the 20
th century, the 
so-called  grand  compilation  of  technologies  such  as 
image-guided  computer-assisted  surgery  and  robotic 
surgery,  has  begun  and  is  being  used  in  clinical 
application. In the future, extremely delicate and precise 
microscopic  surgery  that  cannot  be  performed  by  a 
surgeon can be possible through the combination of new 
surgery support systems and the surgeon’s  skill. Thus, 
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Figure 1  R&D to realise a society of sustainable development (from AIST’s “Second Period Research Strategy”). 
 
 
 
 
 
 
 
Figure 2  Great  Medical  equipment  achievements  elected  by  AIMBE  to  have  most  contributed  to  clinical 
medicine over the past 50 years (AIMBE). 
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progresses  in  medical  treatment  technologies 
simultaneously  promote  the  development  of  medicine 
itself. Many new medical findings, such as the progress 
in  anesthesiology  required  in  awake  surgery,  are 
appearing  in  rapid  succession.  Progress  in  biomedical 
engineering in the 20
th century has greatly transformed 
the  concept  of  health  care  itself,  by  transfiguring  it 
dramatically from a form of “classical medical care” to 
that  of  “leading  edge  medical  care  assisted  by 
instrumentation  and  imaging.”  Furthermore,  social 
demands  to  “enhance  and  maintain  a  high  quality  of 
medical  treatment,  health  and  welfare”  in  this  aging 
society  are  behind  the  anticipation  for  further 
developments in this field in the future. 
The  United  States  established  AIMBE  with  the 
assistance of the National Science Foundation (NSF) and 
others, in February 1992, with the following foresights. 
First,  the  focus  of  medical  technology  will  shift  from 
diagnostic  to  treatment  technology;  progresses  in 
molecular  biology  will  bring  genetic  engineering  into 
diagnostic  technology;  micro-  and  nano-treatment 
technologies  will  be  developed  as  the  ultimate  in 
minimally  invasive  endoscopic  treatment  technology; 
and  further,  regenerative  medicine,  the  ultimate 
treatment  method,  will  become  possible  in  the  near 
future  through  tissue  engineering.  In  AIMBE,  many 
academic societies involved in research and development 
of new medical treatment technologies of the 21
st century 
have united in a common purpose and have been active 
thus.  Later,  in  2001,  the  National  Institute  for 
Bioimaging  and  Bioengineering  (NIBIB)  was  founded 
within  the  National  Institutes  of  Health  (NIH),  based 
upon the foundation of the Bioengineering Consortium 
(BECON). In accordance with this concept for BECON 
in USA, Japan also established the Medical Engineering 
Technology Industrial Strategy (METIS) consortium in 
2001. 
Figure 3 shows the target research topics set forth by 
NIBIB’s first director, Dr. Roderic I. Pettigrew. These 
topics  show  that  movements  in  21
st  century  medical 
technology  are  based  upon  nanomedicine,  regenerative 
medicine and genetic medicine. 
As  analysis  of  the  human  genome  is  virtually 
complete,  medical  technology  will  now  evolve  into  a 
technology where various interdisciplinary technologies 
are multiply combined, from the level of molecules and 
genes below 100 nm, to tissue and organs, and further to 
virtual human science per individual level. In addition to 
the  technology  of  mass  cell  culture,  the  validation 
technology for assuring the quality of the cells and tissue 
produced  is  an  essential  element  in  allowing  medical 
technology employing tissue engineering to mature into a 
clinical technology. Thus the development of minimally 
invasive  measurement  techniques  for  regenerative 
medicine is anticipated. Molecular imaging technology is 
of  growing  interest  with  relevance  to  the  genetic 
treatment technology. Molecular imaging is of potential 
in enabling direct observation of function expression of 
genes  in  genetic  treatments,  while  various  molecular 
imaging  techniques  are  also  anticipated  for  other 
function-specific  imaging.  In  clinical  medicine,  the 
structure  and  function  of  the  protein  produced  by  the 
gene is more often linked directly to the disease rather 
than  the  genetic  information  itself.  The  proteome  is 
attracting  post-genome  attention,  and  it  requires  a 
method  of  analysis  different  from  that  of  the  genome. 
The  protein  chip  is  also  being  developed  as  a  new 
technique. 
BIOMEDICAL ENGINEERING TECHNOLOGY AND 
IMPROVEMENT IN THE QUALITY OF MEDICAL 
TREATMENT 
Endoscopy  may  be  cited  as  a  typical  example  of 
minimally invasive instrumentation technology. In 1950, 
the  gastrocamera  was  developed  in  Japan  for  the  first 
time in the world. Then the prototype of the present-day 
endoscope  was  developed  in  1957,  consisting  of  a 
fiberscope endoscope for extracorporeal observation and 
imaging. Later, the electronic endoscope consisting of an 
endoscope equipped with a CCD camera on its tip was 
developed.  Furthermore,  the  capsule  endoscope  was 
developed  in  the  beginning  of  the  21
st  century.  The 
wireless  capsule  endoscope  manufactured  by  Israel’s 
Given Imaging Ltd. was approved in Europe in May and 
by the U.S. FDA in August of 2001. The small intestine 
is  a  digestive  tract  with  a  total  length  of  7-8  m,  and 
unlike the large intestine, it is virtually unfixed within 
the body cavity. It has been referred to as “the last Dark 
Continent” in gastroenterology. Now, however, the time 
has come for endoscopic technology to demonstrate the 
effect  in  finally  allowing  observation  of  the  entire 
digestive tract. Meanwhile, endoscopic systems are used 
not only in the diagnosis of diseased regions, but are also 
demonstrating great effect in treatments, such as gastric 
polyp snare loop techniques, which began from biopsy 
under direct vision by fiberscope starting in 1965, laser 
 
Figure 3  Direction  of  research  and  development  of  medical 
equipment targeted by NIBIB for the 21
st century. 
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hemostatic  techniques  which  followed,  as  well  as  in 
resections  of  the  gastric  mucous  membrane.  Hence, 
history shows that endoscopic technology is an area in 
which Japan leads the world. At the same time, it has 
technical innovation and market creation ability, as well 
as  competitiveness  of  product  development  against 
Europe  and  U.S.,  as  seen  in  Figure  4,  offering  bright 
prospects  to  Japan’s  medical  equipment  industry  from 
both of these sides. 
In addition, in the future of diagnostic endoscopy, 
this  author  hopes  to  see  alleviation  of  the  discomfort 
experienced upon insertion and during observation (by 
using capsule endoscopes and virtual endoscopy, etc.) as 
well as improvements in diagnostic capabilities (through 
ultra-magnifying endoscopes, confocal laser microscope 
endoscopes,  and  optobiopsies,  which  make  on-the-spot 
“virtual biopsies” and “virtual pathologic examinations” 
possible,  requiring  no  biopsy,  using  an  endoscope 
equipped  with  an  ultra-compact  spectroscope  with 
MEMS on its tip among others). Meanwhile in treatment 
endoscopy,  extended  applications  of  new  minimally 
invasive endoscopic surgical treatments can be expected, 
such as in endoscopic fetal surgery and endoscopic brain 
surgery, as well as further coordination with navigation 
technologies and surgery support systems to allow safe 
execution of these procedures. 
In addition, various developments are anticipated in 
endoscopic treatment techniques, from the conventional 
treatments centering on physical energies, to fusion with 
drug delivery systems as in the case of the drug-eluting 
stent, as well as endoscopic systems fused with cell and 
genetic treatments, to be discussed later. 
MEDICAL IMAGING TECHNOLOGY AND SUSTAINING 
LEADING EDGE MEDICAL TREATMENT 
About 30 years ago, practical application of the X-
ray CT made possible tomography of the human brain, 
thus  revolutionising  the  diagnosis  of  neurological 
disorders.  In  addition,  about  20  years  ago,  MRI  was 
made  clinically  applicable,  and  the  technological 
progress  to  follow  allowed  for  revolutionary 
developments  in  diagnostic  imaging  of  the  total  body. 
Although diagnostic imaging and molecular biology are 
examples  of  the  technologies/disciplines  that  brought 
about significant reform to modern medicine, today, they 
are  attracting  attention  in  the  further  evolved  form  of 
molecular  imaging.  The  morphological  diagnostic 
methods of X-ray CT and MRI are already beneficial for 
functional  diagnosis,  while  SPECT  and  PET  are  even 
becoming  established  as  methods  for  metabolism 
diagnosis. As developments in functional MRI and PET 
have  enabled  for  the  understanding  of  higher  brain 
functions and to conduct molecular function imaging and 
molecular  imaging,  they  are  hoped  to  serve  as  the 
platform  technology  for  genetic  treatment  evaluation 
methods and new drug discoveries. 
The  objective  of  molecular  imaging  is  to  make 
visible the activities of the living body on a molecular 
level  over  time  by  commanding  various  imaging 
methods,  to  thereby  understand  the  significance  of 
molecular mechanisms in life science. The information 
thus obtained is used not only to understand molecular 
mechanisms, but may be used also as the basic data for 
diagnosis. It may potentially provide findings to become 
the seeds for development of new future medicine, such 
as drug developments and application to drug delivery 
techniques. Molecular imaging is regarded as a “specific 
function  imaging,”  thus  targets  for  realising  imaging, 
which  are  currently  being  tried,  include 
neurotransmission/receptor  imaging,  antibody/peptide 
imaging,  and  also  a  genetic  imaging  technique  using 
antisense  and  reporter  genes  (genes  used  to  confirm 
whether or not the gene has actually entered the target 
region by embedding genes of proteins or receptors that 
can be imaged near the target gene for treatment). 
“Molecular imaging” is evolving in two directions: 
(1) visualisation targeting specific molecules in the living 
body, and (2) visualisation on a microscale, in the range 
of  cells.  Future  technical  development  and  research 
needs  to  be  promoted  in  each  of  these  directions.  In 
addition, dynamic time-course visualisation in the form 
of  “molecular  dynamic  imaging”  is  also  an  important 
element. 
The  first  direction  stated  above  is  a  field  best 
performed  by  conventional  nuclear  medical  equipment 
(PET in particular), thus future issues will most likely be 
dominated not by imaging techniques but rather by the 
development  of  drugs  such  as  tracers.  Meanwhile,  the 
second direction above requires technical developments 
in  the  imaging  technology  itself.  New  magnetic 
resonance spectroscopic imaging (MRSI) and other new 
imaging  methods  are  anticipated  to  replace  the 
conventional MRI. In addition, molecular imaging will 
become extremely important as the validation technology 
for regenerative  medicine and cell therapy,  which  will 
lead to progress of great importance to medicine in the 
future. 
Immediate issues in molecular imaging include the 
following: 
1.  Molecular  imaging  is  important  in  many 
aspects of cancer, its largest target. Presently, 
18F-labeled deoxyglucose (FDG), which is also 
used in humans, is becoming the gold standard 
in  cancer  diagnosis,  although  various  other 
techniques are also being explored. In the future, 
the  knowledge  from  cell  biology  needs  to  be 
extended  to  imaging  technology  of  the  entire 
body,  and  to  develop  new  imaging  agents  as 
well.  In  the  metastasis  of  cancer  cells,  the 
relation of in vivo inter-cell bonding is not well 
understood,  but  the  mechanism  of  metastasis 
and  development  of  cancer  is  expected  to  be 
elucidated through imaging. 
2.  Molecular  imaging  is  important  in  molecular 
and  gene  therapies,  where  the  reporter  gene 
must  be  used  effectively.  There  are  two 
techniques  for  molecular  imaging  using  gene 
expression:  antisense  therapy  and  a  method 
using the reporter gene. 
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Figure 4  The competitiveness of Japan’s medical equipment industry and AIST’s role (From AIST’s “Second 
Period Research Strategy”). 
 
 
 
 
 
Figure 5  Biomedical Engineering covered by various worldwide institutions in areas of genome, medicine and 
health (From AIST’s “Second Period Research Strategy”). 
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3.  By  uniting  the  research  of  genes  and  new 
receptors  with  imaging  technologies,  then 
fusing together various methods of imaging, it 
becomes  possible  to  image  the  dynamic 
processes  within  the  living  body.  Then,  by 
further  applying  such  information,  it  is  more 
likely  to  become  applicable  to  diagnosis  and 
assessment of various illnesses, and is expected 
to  allow  easy  viewing  of  the  distribution  of 
drugs used in treatment. 
4.  Optical  technology,  and  the  technology  for 
utilisation of near infrared rays in particular is 
recently  making  remarkable  progress.  The 
possibility for light from substances within the 
body  to  be  imaged  by  tomography  using  this 
technology  allows  various  things  to  be 
employed  as  reporter  genes.  Continuous 
changes  can  then  be  observed  for  prolonged 
periods  using  optical  technology,  unlike  the 
case  with  PET  which  is  not  practical  as  it 
causes exposure. 
As  described  above,  in  molecular  imaging,  the 
knowledge of molecular biology and also interfaces with 
various  engineering  technologies  are  crucial.  Thus,  in 
addition  to  the  collaboration  between  medicine, 
engineering  and  industry  advocated  nowadays,  further 
coordination with medicine and biology is also required. 
THE ROLE OF BIOMEDICAL ENGINEERING IN THE 
FUTURE 
As illustrated above, medical technology has been 
experiencing  significant  transformations  since  entering 
the 21
st century. In addition to conventional technologies, 
biotechnology and nanotechnology made applicable are 
being fused anew into medical technology. The advanced 
health  care  that  citizens  benefit  from  every  day  is 
realised  upon  the  latest  medical  knowledge  and 
equipment/technology.  Medical  equipment  has,  in  the 
past,  shown  progress  every  ten  years.  Computerisation 
and  systemisation  of  measuring  and  monitoring 
equipment  for  biophenomena  was  implemented  in  the 
1960s; various medical imaging technologies were born 
in the 1970s;  minimally invasive endoscopic diagnosis 
and treatment technologies appeared in the 1980s; and 
robotic surgery was realised in the 1990s. An extremely 
interesting  fact  is  the  Japanese  medical  system  also 
underwent  radical  transformations  in  sync  with  these 
stages. In the 1960s, it was “scale-up of the volume of 
health care” by establishing more medical facilities; in 
the 1970s, it was “improvement in the quality of health 
care”; in the 1980s, it was “the issue of medical costs”; 
and finally in the 1990s, it was “the balance between cost 
and quality of health care.” The nature of Japan’s health 
care has actually been affected directly by the progress in, 
and supply of, medical equipment and technologies. The 
fact  constitutes  a  typical  example  of  the  coordination 
between  technical  development  and  the  social  system, 
suggesting  that  developments  in  medical  technologies 
are not merely limited to the realm of scientific research. 
A stable supply of advanced health care quite simply 
represents  the  needs  of  the  public  and  society.  In  the 
future,  “translational  research”  needs  to  be  urgently 
constructed and should consist of  “basic  medicine and 
engineering  research”  such  as  the  combination  of  bio- 
and nanotechnologies and further augmented with new 
knowledge.  These  outcomes  are  then  used  to  actually 
implement  Product  Realisation  Research  for  supply  to 
the clinical medicine. Figure 5 is an outline of the range 
of  activities  covered  by  NIH,  the  world-leading  U.S. 
research institute, in the fields of genome, medicine, and 
health,  as  well  as  Japan’s  RIKEN,  various  research 
institutes of the Ministry of Health, Labour and Welfare, 
and government institutions. AIST’s life sciences-related 
research units are required to engage in basic research 
from an industrial perspective not covered by any of the 
above,  namely  “the  phase  of  searching  for  seeds  and 
actively  linking  them  to  products,  and  the  scientific 
evaluation of product functions.” AIST thereby plays an 
indispensable function in promoting medical equipment 
industry. 
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